State and DC Legislators Write Senate on Health Reform - Protest Data Exclusivity Provisions for Biogenerics
National Legislative Association on Prescription Drug Prices sent a letter to Senate Majority Leader Harry Reid urging that he amend the Patient Protection and Affordable Care Act to more directly and effectively lower the cost of pharmaceuticals. The letter included criticism of the biogeneric provisions that would allow brand name firms to use consecutive 12 year periods of data exclusivity to block generic entry.









